North America is one of the leading regions in the Gastrointestinal Agents market, supported by a high prevalence of digestive disorders such as GERD, irritable bowel syndrome, inflammatory bowel disease, and chronic constipation. The region benefits from advanced healthcare infrastructure, strong diagnostic capabilities, and the presence of major pharmaceutical companies that continue to...